Hanna Szweda

Mrs. Hanna Szweda


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2018 in Computerized Medical Imaging and Graphics
Verified
Journal Article
Closed access
Krzysztof J. OpielińskiKrzysztof J. Opieliński
Krzysztof J. Opieliński
PPPiotr Pruchnicki
Piotr Pruchnicki
PSPawel Szymanowski
Pawel Szymanowski
WSWioletta Katarzyna Szepieniec
Wioletta Katarzyna Szepieniec
HSHanna Szweda
Hanna Szweda
MBMariusz Bułkowski
Mariusz Bułkowski

26 July 2024 in Ginekologia Polska
Verified
Journal Article
Open access
PDF file
PSPawel Szymanowski
Pawel Szymanowski
WSWioletta K. Szepieniec
Wioletta K. Szepieniec
HSHanna Szweda
Hanna Szweda
JLJanusz Ligeza
Janusz Ligeza
ASAnna Sadakierska-Chudy
Anna Sadakierska-Chudy
Objectives: Lack of standardization causes misunderstandings in planning of cystocele treatment and the evaluation of surgical method effectiveness. The POP-Q System and DeLancey’s three levels of pelvic support do not account for the phenomenon of cystocele caused by an apical defect. We aimed to evaluate the impact of level I defect on the formation of cystocele. Material and methods: Women reporting complaints related to bladder prolapse (cystocele) were subjected to a urogynecological examination. For this purpose, a simple and standardized method was used, based on the POP-Q System and DeLancey’s three levels of pelvic support. Furthermore, it was expanded by evaluating the impact of level I defect (apical defect) on prolapse at level II of the anterior compartment. Results: In total, contribution of an apical defect to the pathogenesis of cystocele was founded in 72.2% of 302 female patients included in this study. In 30.8% the cystocele was caused exclusively by an apical defect. In turn, in 41.4% of patients, it resulted from concomitant apical and level II defect of the anterior compartment (lateral or central). Conclusions: The results of this study indicate that an apical defect may play a significant role in the development of a cystocele. Hence, it could be essential to take the influence of an apical defect on level II in anterior compartment into account when planning a surgical procedure. The authors suggest that lack of such procedures potentially exposes some cystocele patients to ineffective treatment. Objectives: Lack of standardization causes misunderstandings in planning of cystocele treatment and the evaluation of surgical method effectiveness. The POP-Q System and DeLancey’s three levels of pelvic support do not account for the phenomenon of cystocele caused by an apical defect. We aimed to evaluate the impact of level I defect on the formation of cystocele. Material and methods: Women reporting complaints related to bladder prolapse (cystocele) were subjected to a urogynecological examination. For this purpose, a simple and standardized method was used, based on the POP-Q System and DeLancey’s three levels of pelvic support. Furthermore, it was expanded by evaluating the impact of level I defect (apical defect) on prolapse at level II of the anterior compartment. Results: In total, contribution of an apical defect to the pathogenesis of cystocele was founded in 72.2% of 302 female patients included in this study. In 30.8% the cystocele was caused exclusively by an apical defect. In turn, in 41.4% of patients, it resulted from concomitant apical and level II defect of the anterior compartment (lateral or central). Conclusions: The results of this study indicate that an apical defect may play a significant role in the development of a cystocele. Hence, it could be essential to take the influence of an apical defect on level II in anterior compartment into account when planning a surgical procedure. The authors suggest that lack of such procedures potentially exposes some cystocele patients to ineffective treatment.

12 April 2021 in Diagnostics
Verified
Journal Article
Open access
PDF file
WSWioletta Katarzyna Szepieniec
Wioletta Katarzyna Szepieniec
HSHanna Szweda
Hanna Szweda
MWMaksym Wróblewski
Maksym Wróblewski
PSPaweł Szymanowski
Paweł Szymanowski
Background: To present a new method of urethral pressure examination, and to evaluate diagnostic capabilities of three-dimensional profilometry, as an alternative to classical urethral profile (UPP). Using five channel catheters and dedicated software, a global urethral pressure image is obtained. The method eliminates the main limitation of classical urethral profilometry, where the catheter orientation determines the pressure picture limited to only one point in the urethral circumference; we observed up to 50% differences in pressure measures depending on the point of urethral circumference where the measurement was taken. Methods: This is a preliminary study containing a method presentation and analysis of the use in varied clinical cases of either healthy patients or patients with lower urinary tract symptoms (LUTS). The article includes a technique and equipment description and a full evaluation of selected cases, including three-dimensional urethral pressure distribution graphics. Results and Conclusions: Three-dimensional profilometry compared to the classical technique is comparable regarding the time, cost, technical difficulty and patient discomfort. At the same time, we obtained much more data on the urethral pressure and its distribution. The results are easy to interpret due to the 3D movable graphics created automatically by the dedicated software.

1 January 2021 in Ginekologia Polska
Verified
Journal Article
Closed access
PDF file
PSPawel Szymanowski
Pawel Szymanowski
WSWioletta K. Szepieniec
Wioletta K. Szepieniec
HSHanna Szweda
Hanna Szweda
Objectives:The aim of this study is to present a novel approach for a paravaginal defect treatment. This extraperitoneal approach can be performed in patients with comorbidities and on obese patients.The main advantages are: not requiring the pneumoperitoneum and the Trendelenburg position and the avoidance of peritoneal adhesions. Material and methods: This study presents the results in 27 patients with cystocele caused by a lateral defect pelvic organ prolapse quantification (POP Q) stage II or higher.The procedure was performed with a modified Richardson and Burch technique using a preperitoneal approach. Three follow-up examinations were conducted two, six weeks, and six months after the operation. A quality of life assessment was conducted before and after surgery using the short form of the PFIQ-7. Results: All patients had a POP Q II cystocele and 59% had concomitant stress urinary incontinence. In all patients cystocele was reduce to asymptomatic POP Q stage I or 0. Mean operation time was approximately 80 minutes. In six months post-operation follow up, one case of recurrence was noted.The patients'quality of life revealed a statistical improvement from an average of 6.8 points before, to an average of 0.7 points after the operation (p < 0.05) in the PFIQ-7. Conclusions: Preperitoneal laparoscopic lateral repair is a relatively fast procedure and it is also feasible for obese women and for patients with a cardiopulmonary risk. Neither the Trendelenburg position nor the pneumoperitoneum are required. Postoperatively, the patients witnessed a reduction of the cystocele and complaints connected with their previous condition.

26 October 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Edyta Maria Tulewicz-MartiEdyta Maria Tulewicz-Marti
Edyta Maria Tulewicz-Marti
HSHanna Szweda
Hanna Szweda
PGPatrycja Gumula
Patrycja Gumula
ISIzabela Sierakowska
Izabela Sierakowska
KLKonrad Lewandowski
Konrad Lewandowski
GRGrażyna Rydzewska
Grażyna Rydzewska
Background: Data on cervical cytological abnormalities in women with inflammatory bowel disease (IBD) are inconsistent. We compared their prevalence in women with and without IBD. Methods: In this retrospective single-centre analysis of electronic medical records (2022–2024), women with Crohn’s disease (CD) or ulcerative colitis (UC) were compared with 141 women treated at a gynaecology outpatient clinic. Cytology was classified exclusively using the Bethesda System (abnormal = ASC-US or worse; “Pap II” inflammation = normal). Results: Of 301 women with IBD, 280 (141 CD, 139 UC) had evaluable cytology. The most recent cytology assessment was abnormal in 4/280 women with IBD (1.4%) versus 13/141 controls (9.2%; OR 0.14, 95% CI 0.05–0.45); a current or historical abnormality was identified in 12/280 women with IBD (4.3%) versus 13/141 controls (9.2%; OR 0.44, 95% CI 0.20–0.99; p = 0.051). CD and UC did not differ, and no clinical or treatment variable was associated with abnormality (12 events). hrHPV testing was documented in 15.7% of women with IBD (controls 85.8%). Conclusions: Abnormal cytology was infrequent in this closely monitored IBD cohort and numerically lower than in controls; however, the controls comprised a selected group, HPV testing differed between groups, and events were few, so an increased risk cannot be excluded. Regular gynaecological surveillance remains essential.

27 February 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
Edyta Maria Tulewicz-MartiEdyta Maria Tulewicz-Marti
Edyta Maria Tulewicz-Marti
HSHanna Szweda
Hanna Szweda
SISierakowska I.
Sierakowska I.
KLKonrad Lewandowski
Konrad Lewandowski
KJKaptur J.
Kaptur J.
GRGrażyna Rydzewska
Grażyna Rydzewska
Introduction: Existing data on cervical intraepithelial neoplasia (CIN) in individuals with inflammatory bowel disease (IBD) are inconsistent. The aim of this study was to evaluate the prevalence of abnormal cervical cytology among patients with IBD. Methods: A retrospective analysis was conducted using digital records from patients with IBD, including those receiving immunosuppressive therapy, small molecules, or biological treatments, to assess the influence of these therapies on cervical cytology results. Results: Data were collected from 301 patients with IBD (150 with Crohn’s disease [50.3%] and 151 with ulcerative colitis [49.8%]) and 40 control patients. The mean age in the IBD group was 36.96 ± 11.92 years for Crohn’s disease and 43.19 ± 14.42 years for ulcerative colitis (mean difference = -6.23, 95% CI [-9.23; -3.23]), while the control group had a mean age of 36.55 ± 12.70 years. Deviations from normal findings in the most recent cytology were observed in 6 IBD patients (2.3%) compared to 8 control patients (20.0%), OR = 0.10, 95% CI [0.03; 0.34], p < 0.001. Deviations from normal findings in the most recent cytology or an y previous cytology were identified in 25 IBD patients (9.0%) versus 9 controls patients (22.5%), OR = 0.34, 95 % CI [0.14; 0.91], p = 0.021. No significant differences were found between the IBD subgroups regarding smoking status, current or past exposure to immunosuppressive drugs, or frequency of gynaecological examinations. The frequency of biological treatment was higher in Crohn’s disease patients (88.0%) compared to those with ulcerative colitis (74.2%) (OR = 2.55, 95% CI [1.36; 5.01], p = 0.003). Conclusions: Women with IBD exhibited a lower risk of cervical dysplasia compared to healthy controls, independent of treatment type. However, rigorous malignancy surveillance, including regular cervical cytology, remains essential to facilitate early detection of dysplasia.